Anti-hepatitis b virus agent
AssigneesDaikin Industries, Ltd., Kagoshima University
InventorsTomohito HAMADA, Yosuke KISHIKAWA, Kanako INOO, Masanori IKEDA, Midori TAKEDA
Life of this patent
Estimating the term…
Abstract
The present disclosure provides an anti-hepatitis B virus agent and a prophylactic or therapeutic agent for hepatitis B virus-related diseases, each comprising a nucleic acid analogue as an active ingredient. The problem can be solved by 2′-deoxy-2′-fluoro-β-2-fluoro-D-adenosine or its prodrug, or a pharmaceutically acceptable salt thereof, or a solvate thereof.
Claims3
An anti-hepatitis B virus agent comprising, as an active ingredient, 2′-deoxy-2′-fluoro-β-2-fluoro-D-adenosine or its prodrug, or a pharmaceutically acceptable salt thereof, or a solvate thereof.
A prophylactic or therapeutic agent for a hepatitis B virus-related disease, comprising, as an active ingredient, 2′-deoxy-2′-fluoro-β-2-fluoro-D-adenosine or its prodrug, or a pharmaceutically acceptable salt thereof, or a solvate thereof.
Dependencies are inferred from the claim text.